Consistently, we found that Immune C1 [Wound Healing, which is closely associated with high cancer stemness (25)] showed higher EL than Immune C2 (IFN-gamma Dominant) (two-sided Wilcoxon test, P=0.042 in TGCT, P=0.031 in UCS, and P<0.001 in BRCA), and Immune C3 [Inflammatory, which can enhance cancer stemness (25)] showed higher EL than Immune C4 (Lymphocyte Depleted) (two-sided Wilcoxon test, P<0.01 in both BRCA and in PCPG) (Figure S3). Here, IFNG is linked to cancer.